Colgate-Palmolive Company $CL Shares Purchased by Alliancebernstein L.P.

Alliancebernstein L.P. boosted its stake in shares of Colgate-Palmolive Company (NYSE:CL) by 18.3% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,460,538 shares of the company’s stock after purchasing an additional 379,880 shares during the quarter. Alliancebernstein L.P.’s holdings in Colgate-Palmolive were worth $196,695,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of the stock. Copia Wealth Management purchased a new stake in shares of Colgate-Palmolive during the third quarter worth approximately $29,000. Vermillion & White Wealth Management Group LLC lifted its stake in Colgate-Palmolive by 86.1% in the second quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company’s stock worth $30,000 after acquiring an additional 155 shares during the last quarter. Cloud Capital Management LLC acquired a new position in Colgate-Palmolive during the 3rd quarter worth approximately $30,000. Kelleher Financial Advisors acquired a new position in Colgate-Palmolive during the 3rd quarter worth approximately $35,000. Finally, MTM Investment Management LLC purchased a new stake in shares of Colgate-Palmolive in the 2nd quarter valued at approximately $39,000. Institutional investors and hedge funds own 80.41% of the company’s stock.

Insider Activity

In other Colgate-Palmolive news, COO Panagiotis Tsourapas sold 35,000 shares of Colgate-Palmolive stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $94.61, for a total value of $3,311,350.00. Following the sale, the chief operating officer owned 10,415 shares of the company’s stock, valued at approximately $985,363.15. The trade was a 77.07% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Stanley J. Sutula III sold 97,843 shares of the business’s stock in a transaction that occurred on Wednesday, February 4th. The stock was sold at an average price of $94.27, for a total value of $9,223,659.61. Following the transaction, the chief financial officer owned 55,310 shares in the company, valued at $5,214,073.70. The trade was a 63.89% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 184,683 shares of company stock valued at $17,486,693. 0.41% of the stock is owned by insiders.

Analyst Ratings Changes

CL has been the subject of several recent analyst reports. Wells Fargo & Company lifted their price objective on shares of Colgate-Palmolive from $86.00 to $94.00 and gave the stock an “equal weight” rating in a research report on Sunday, February 1st. Rothschild & Co Redburn set a $93.00 target price on Colgate-Palmolive in a report on Friday, February 13th. Barclays lifted their price target on Colgate-Palmolive from $83.00 to $88.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 3rd. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Colgate-Palmolive in a research report on Wednesday, January 21st. Finally, Morgan Stanley increased their price objective on Colgate-Palmolive from $87.00 to $100.00 and gave the company an “overweight” rating in a report on Monday, February 2nd. Eleven research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat.com, Colgate-Palmolive presently has an average rating of “Moderate Buy” and an average target price of $94.75.

Colgate-Palmolive Price Performance

Colgate-Palmolive stock opened at $90.39 on Tuesday. The company has a debt-to-equity ratio of 18.82, a current ratio of 0.83 and a quick ratio of 0.54. The business has a 50 day simple moving average of $90.38 and a 200-day simple moving average of $83.27. Colgate-Palmolive Company has a 12 month low of $74.54 and a 12 month high of $99.33. The stock has a market capitalization of $72.86 billion, a PE ratio of 34.50, a price-to-earnings-growth ratio of 3.98 and a beta of 0.28.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, January 30th. The company reported $0.95 earnings per share for the quarter, beating analysts’ consensus estimates of $0.91 by $0.04. The firm had revenue of $5.23 billion for the quarter, compared to analyst estimates of $5.13 billion. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. Colgate-Palmolive’s quarterly revenue was up 5.8% on a year-over-year basis. During the same period last year, the firm posted $0.91 EPS. Equities analysts predict that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Monday, April 20th will be issued a $0.53 dividend. The ex-dividend date of this dividend is Monday, April 20th. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.52. This represents a $2.12 annualized dividend and a dividend yield of 2.3%. Colgate-Palmolive’s payout ratio is presently 79.39%.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.